Our Newest Size Exclusion Chromatography Column for Monoclonal Antibodies: YMC-SEC MAB
October 5, 2018
At YMC America, Inc., you can buy analytical columns to meet your most demanding applications. Now, we are pleased to announce our newest analytical column: YMC-SEC MAB. This silica-based size exclusion chromatography column consists of a dihydroxypropyl stationary phase bonded to a silica gel base, and has been specifically designed for high-resolution analysis of monoclonal antibody products. Key [...]
Strongly Growing TOPTICA expands Management Team
October 5, 2018
From Oct 1st 2018, Dr. Thomas Renner, VP Sales & Marketing since 2005, will join the Vorstand of TOPTICA Photonics AG, which expands from 2 to 3 members. Next to the company founders Dr. Wilhelm Kaenders (Technology) and Dr. Thomas Weber (Operations & Finance) Dr. Renner will become responsible for sales, marketing and product management, [...]
October 5, 2018
Photo collage of images with improved Imaging In Flow Great news! We have developed a major improvement for our instruments with Imagining-In-Flow. The system can now be set to ONLY photograph particles on their way to traverse the focal plane of the camera. This means no more obstruction of the image stream by out of [...]
October 4, 2018
Purpose Designed with All the Calibrations and Accessories Needed for an Entry-level Handheld XRF Analyzer WESTFORD, MA / ACCESSWIRE / Hitachi High-Tech Analytical Science Corporation (Hitachi High-Tech Analytical Science), a Hitachi High-Technologies Corporation (TSE: 8036) wholly owned subsidiary engaged in the manufacture and sales of analysis and measuring instruments, has introduced a new entry-level handheld X-ray [...]
October 4, 2018
BGI has analyzed the world’s largest set of genome data from pregnant women, a total 141,431 expectant mothers from across China, in a groundbreaking study published today in the leading academic journal Cell. The genomic analyses from non-invasive prenatal testing (NIPT) revealed new genetic associations, patterns of viral infections, and history in Chinese populations. The study is the [...]
Blackstone Announces Agreement to Acquire Clarus, a Leading Life Sciences Investment Firm
October 4, 2018
Firm Announces Launch of Blackstone Life Sciences Investment Platform New York – Blackstone (NYSE:BX) today announced that it has agreed to acquire Clarus, a leading global life sciences investment firm that has raised $2.6 billion since its founding. Clarus, with offices in the life sciences hubs of Boston and San Francisco, is focused on funding growth-stage [...]
October 4, 2018
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- IQVIA™ (NYSE:IQV) and Genomics England today announced a collaboration to develop a platform that will connect clinical and de-identified genomics data to accelerate treatment advancements for patients. This alliance will enable faster and more efficient drug research, more robust evidence to support treatment value, and greater access [...]
INFICON Acquires Final Phase Systems
October 4, 2018
End-to-end Software Solution for Fully Connected Smart Fab of the Future SYRACUSE, N.Y.--On October 1, 2018 INFICON Inc. (SWX:IFCN), a leading supplier of vacuum instrumentation and process control software to the semiconductor manufacturing industry acquired all assets of Final Phase Systems (FPS) of Austin, Texas, USA. Founded in 2009 by Industrial Engineers from AMD/Spansion’s Fab25, FPS has grown to [...]
October 4, 2018
Location: Cambridge, UK In vivo study results to be presented at the 2018 SITC Annual Meeting Celyad (Paris:CYAD) (Brussels:CYAD) (NASDAQ:CYAD) (Euronext Brussels and Paris, and NASDAQ: CYAD), a clinical-stage biopharmaceutical company focused on the development of specialized CAR-T cell-based therapies, today announced an exclusive agreement with Horizon Discovery Group plc (LSE: HZD), for the use [...]
AXCELEAD DRUG DISCOVERY PARTNERS AND ERS GENOMICS ENTER INTO CRISPR/CAS9 LICENSE AGREEMENT
October 4, 2018
Fujisawa, Japan and Dublin, Ireland – Axcelead Drug Discovery Partners, Inc.(hereinafter referred to as “Axcelead”) and ERS Genomics Limited (hereinafter referred to as “ERS Genomics”) announced today a non-exclusive license agreement to provide Axcelead with worldwide access to ERS Genomics’ CRISPR/Cas9 genome editing intellectual property to enhance their drug discovery service offering. ERS Genomics holds rights [...]
